Bajaj Finserv Mutual Fund increased its stake in Senores Pharmaceuticals Limited from 1.19% to 1.79%, purchasing 2,76,025 shares.
A pharmaceutical manufacturer that produces complex generic medicines certified by global regulatory authorities including the FDA and WHO. Incorporated in 2015, the company focuses on developing and supplying affordable, high-quality pharmaceutical formulations to domestic and international markets. Its operations center on manufacturing specialized generics that address critical therapeutic areas while maintaining stringent international quality standards and compliance requirements.
AMC subsidiary of Bajaj Finserv, India's leading non-banking financial services conglomerate. Launched in 2023 with an aggressive passive-first strategy, offering index funds and ETFs at competitive expense ratios to challenge incumbents in the rapidly growing passive segment. One of the fastest-growing new entrants in the AMC space with strong distribution from Bajaj Finserv's vast financial services network.
